1st Quarter - Report

PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2011 $50,000 Replaced
1st Quarter - Amendment May 24, 2011 $50,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Diabetes issues, generally. Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
SHARON COHEN —
STEPHEN NORTHRUP —
ANNE MARIE POLAK —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare coverage and reimbursement issues.

LobbyistCovered position, as disclosed
SHARON COHEN —
STEPHEN NORTHRUP —
ANNE MARIE POLAK —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Prescription Drug User Fee Act reauthorization. FDA issues, generally.

LobbyistCovered position, as disclosed
SHARON COHEN —
STEPHEN NORTHRUP —
ANNE MARIE POLAK —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Diabetes research issues.

LobbyistCovered position, as disclosed
SHARON COHEN —
STEPHEN NORTHRUP —
ANNE MARIE POLAK —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

H.R. 1249/S. 23, America Invents Act.

LobbyistCovered position, as disclosed
SHARON COHEN —
STEPHEN NORTHRUP —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.